Research and Development

Showing 15 posts of 9573 posts found.

servier image

Servier slammed over UK trial transparency failure

September 8, 2014 Medical Communications, Research and Development, Sales and Marketing ABPI, PMCPA, Servier, code, conduct, transparancy, trials

Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …
merck image

BMS sues Merck over new melanoma drug

September 8, 2014 Research and Development, Sales and Marketing BMS, FDA, Merck, PD-1 inhibitors, Yervoy, keytruda

Things are getting ugly between Bristol-Myers Squibb and Merck as the former company began legal proceedings against the latter over …
BMS image

Bristol-Myers Squibb: following the string of pearls

September 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions

Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …
david_caumartin

Theraclion hires chief executive and VP

September 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anja Kleber, David Caumartin, Theraclion

French medical device firm Theraclion has appointed David Caumartin as its chief executive and Anja Kleber as vice president of …

Merck surprise winner in PD-1 race

September 5, 2014 Medical Communications, Research and Development, Sales and Marketing Cancer, Merck, melanoma, pd-1

Merck has become the first company to bring a new class of cancer drug to the US market after the …

J&J fast-track Ebola vaccine for early 2015 trials

September 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, Mapp, zmapp

Johnson & Johnson has announced it is to fast-track the development of a new vaccine programme to fight the deadly …
Infinity image

AbbVie and Infinity sign cancer deal

September 4, 2014 Research and Development, Sales and Marketing AbbVie, IPI-145, blood cancer, duvelisib, infinity

AbbVie has partnered with US company Infinity Pharmaceuticals to develop and commercialise the latter firm’s blood cancer treatment duvelisib (IPI-145). …
annalises_cmaeron

New chief executive for Healthcare Communications Association

September 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anneliese Cameron, HCA, Healthcare Communications Association, julia cook

The Healthcare Communications Association (HCA) has a new chief executive in Anneliese Cameron who replaces Julia Cook next year in …
Google image

Google partners with AbbVie on ageing

September 4, 2014 Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google

Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …
icon_spectre

ICON appoints vice president from Allergan

September 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, ira spector

Healthcare outsourced development firm ICON has hired Dr Ira Spector to be the executive vice president of its analytics and …

BioData appoints new chief executive

September 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Louis Culot, biodata, culot

Digital science portfolio firm BioData that produces web-based research and lab management service Labguru, has appointed Louis Culot as its …
Haslam image

NICE: Cancer Drugs Fund must use our processes

September 3, 2014 Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche

NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …
Novo Nordisk image

Novo Nordisk scraps inflammatory disorders business

September 2, 2014 Research and Development, Sales and Marketing Danish, IL20, Novo Nordisk, diabetes, inflammatory, thomsen

A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …
marie-agnes_heine

EMA hires head of comms and HR

September 2, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Manuel Ortigão, Marie-Agnes Heine

The European Medicines Agency has confirmed two new appointments to join its management team.  Marie-Agnes Heine (pictured) has joined to …
Cancer image

Children’s cancer death rates drop

September 2, 2014 Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, Cancer Research UK, child, death rates

The rate of children dying from cancer has dropped by 22% in the last decade, according to new data published …
The Gateway to Local Adoption Series

Latest content